Sustained HBsAg seroclearance after pembrolizumab-containing neoadjuvant therapy in a patient with synchronous esophageal and gastric cancer: a case report
Zerong Wang, Chongyuan Sun, Penghui Niu, Danjun Wang, Xue Han, Lulu Zhao et al. Sustained HBsAg seroclearance after pembrolizumab-containing neoadjuvant therapy in a patient with synchronous esophageal and gastric cancer: a case report. // BMC Gastroenterology. – 2026. – DOI: 10.1186/s12876-026-05443-8. – URL: https://doi.org/10.1186/s12876-026-05443-8
Zerong Wang, Chongyuan Sun, Penghui Niu, Danjun Wang, Xue Han, Lulu Zhao, Dongbing Zhao, & Yingtai Chen (2026). Sustained HBsAg seroclearance after pembrolizumab-containing neoadjuvant therapy in a patient with synchronous esophageal and gastric cancer: a case report. BMC Gastroenterology. https://doi.org/10.1186/s12876-026-05443-8
Zerong Wang, et al. “Sustained HBsAg seroclearance after pembrolizumab-containing neoadjuvant therapy in a patient with synchronous esophageal and gastric cancer: a case report.” BMC Gastroenterology, 2026. doi:10.1186/s12876-026-05443-8.
@article{Wang2026,
title = {Sustained HBsAg seroclearance after pembrolizumab-containing neoadjuvant therapy in a patient with synchronous esophageal and gastric cancer: a case report},
author = {Wang, Zerong and Sun, Chongyuan and Niu, Penghui and Wang, Danjun and Han, Xue and Zhao, Lulu and Zhao, Dongbing and Chen, Yingtai},
journal = {BMC Gastroenterology},
year = {2026},
doi = {10.1186/s12876-026-05443-8},
url = {https://doi.org/10.1186/s12876-026-05443-8}
}